The global hemoglobinopathy market (Marché de l’hémoglobinopathie) is projected to reach a value of US$ 788.1 million by 2024 and is expected to grow at a compound annual growth rate (CAGR) of 8.3%, reaching approximately US$ 1,745.7 million by 2034.
Hemoglobinopathies are prevalent in regions such as sub-Saharan Africa, the Mediterranean, the Middle East, and parts of...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek